Taiwan Biomaterial Co., Ltd. (6649.TWO)
Taipei Exchange · TWD · Healthcare · Medical Devices
NT$37.55 (+0.94%) as of
Key statistics
- Market cap
- 1.58B
- P/E (TTM)
- 47.53
- EPS (TTM)
- 0.79
- Dividend yield
- 2.69%
- 52-week range
- 34.15 – 68.40
- Beta
- 0.41
- Revenue (TTM)
- 182.32M
- Profit margin
- 18.19%
- Volume
- 9.28k
About Taiwan Biomaterial Co., Ltd.
Taiwan Biomaterial Co., Ltd. engages in the development and sale of implantable medical devices in Taiwan. It provides Foamagen, a foamagen dura substitute; stroke thrombus negative pressure removal catheter system comprising suction and removal of cerebrovascular embolism blood clot for the pump system, and nickel-titanium guidewire for guiding cerebral vascular surgery; tissue repair and regeneration products for the treatment of early osteoarthritis; and CDMO. The company was founded in 1921 and is based in Zhubei, Taiwan.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Zhubei, Taiwan
- Employees
- 46
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.